HomeCompareLDXHF vs MO

LDXHF vs MO: Dividend Comparison 2026

LDXHF yields 1238.39% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LDXHF wins by $124493861.46M in total portfolio value
10 years
LDXHF
LDXHF
● Live price
1238.39%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124493861.54M
Annual income
$107,429,031,462,338.22
Full LDXHF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — LDXHF vs MO

📍 LDXHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLDXHFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LDXHF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LDXHF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LDXHF
Annual income on $10K today (after 15% tax)
$105,263.16/yr
After 10yr DRIP, annual income (after tax)
$91,314,676,742,987.48/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, LDXHF beats the other by $91,314,676,717,352.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LDXHF + MO for your $10,000?

LDXHF: 50%MO: 50%
100% MO50/50100% LDXHF
Portfolio after 10yr
$62246930.81M
Annual income
$53,714,515,746,248.69/yr
Blended yield
86.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

LDXHF
No analyst data
Altman Z
-3.3
Piotroski
3/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LDXHF buys
0
MO buys
0
No recent congressional trades found for LDXHF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLDXHFMO
Forward yield1238.39%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$124493861.54M$80.1K
Annual income after 10y$107,429,031,462,338.22$30,159.17
Total dividends collected$123225412.32M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LDXHF vs MO ($10,000, DRIP)

YearLDXHF PortfolioLDXHF Income/yrMO PortfolioMO Income/yrGap
1← crossover$134,539$123,839.01$10,570$780.30+$124.0KLDXHF
2$1,701,076$1,557,119.40$11,381$1,032.90+$1.69MLDXHF
3$20,219,975$18,399,823.95$12,535$1,392.73+$20.21MLDXHF
4$226,038,135$204,402,761.69$14,193$1,920.91+$226.02MLDXHF
5$2,377,382,925$2,135,522,120.49$16,618$2,723.68+$2377.37MLDXHF
6$23,535,021,639$20,991,221,908.63$20,263$3,993.80+$23535.00MLDXHF
7$219,391,496,761$194,209,023,607.94$25,936$6,098.36+$219391.47MLDXHF
8$1,926,711,724,815$1,691,962,823,279.82$35,166$9,775.01+$1926711.69MLDXHF
9$15,948,439,325,295$13,886,857,779,743.26$51,026$16,597.78+$15948439.27MLDXHF
10$124,493,861,540,404$107,429,031,462,338.22$80,113$30,159.17+$124493861.46MLDXHF

LDXHF vs MO: Complete Analysis 2026

LDXHFStock

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Full LDXHF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this LDXHF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LDXHF vs SCHDLDXHF vs JEPILDXHF vs OLDXHF vs KOLDXHF vs MAINLDXHF vs PMLDXHF vs BTILDXHF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.